SCHEMBL30539751

SCHEMBL30539751

Cn1c(=O)c(C(=O)NCc2ccc(C#N)cc2)cc2nccc(OCC3(S(N)(=O)=O)CC3)c21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1B1 P15121 1/20 0.39
▸ KLKB1 P03952 1/20 0.37
▸ KLK1 P06870 1/20 0.37
▸ CA12 O43570 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CA7 P43166 1/20 0.36
▸ ROS1 P08922 1/20 0.35
▸ ALK Q9UM73 1/20 0.35
▸ ROCK2 O75116 2/20 0.34
▸ MAPK8 P45983 2/20 0.34
▸ MAPK9 P45984 2/20 0.34
▸ AURKA O14965 1/20 0.34
▸ CSF1R P07333 1/20 0.34
▸ RPS6KB1 P23443 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ AKT1 P31749 1/20 0.34
▸ CSNK1D P48730 1/20 0.34
▸ PRKD2 Q9BZL6 1/20 0.34
▸ ABCB1 P08183 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25344184 1.00 AKR1B1 (0.39) AKR1B1KLKB1KLK1CA12CA1
SCHEMBL25981509 0.93 AKR1B1 (0.40) AKR1B1KLKB1KLK1ROS1ALK
SCHEMBL30539550 0.92 AKR1B1 (0.38) AKR1B1KLKB1KLK1CA12CA1
SCHEMBL25350193 0.92 AKR1B1 (0.38) AKR1B1KLKB1KLK1CA12CA1
SCHEMBL30539580 0.92 AKR1B1 (0.39) AKR1B1KLKB1KLK1ROS1ALK
SCHEMBL25348067 0.92 AKR1B1 (0.39) AKR1B1KLKB1KLK1ROS1ALK
SCHEMBL25348040 0.91 AKR1B1 (0.38) AKR1B1KLKB1KLK1ROS1ALK
SCHEMBL30539654 0.91 AKR1B1 (0.38) AKR1B1KLKB1KLK1ROS1ALK
SCHEMBL25990243 0.91 AKR1B1 (0.38) AKR1B1KLKB1KLK1ROS1ALK
SCHEMBL25345925 0.90 AKR1B1 (0.38) AKR1B1KLKB1KLK1ROS1ALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4479388-A1 ANTIVIRAL NAPHTHYRIDINONE COMPOUNDS Gilead Sciences, Inc. (US) 2024-12-25 — — EP disclosed
WO-2023154905-A1 ANTIVIRAL PYRAZOLOPYRIDINONE COMPOUNDS GILEAD SCIENCES, INC. (US) 2023-08-17 — — WO disclosed
Send feedback